Evaluation of the Performance and Safety of VACUSERA® PRP Tubes in the Preparation of Autologous Platelet-Rich Plasma

Active, not recruitingOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
No Disease or Condition is Being Studied
Interventions
DEVICE

The study is entirely designed to analyze product performance (analyze only results from whole blood and derived from the PRP tubes), and no interventions will be performed.

The study will evaluate and analyze only the results obtained from whole blood in the hemogram test and the results derived from the PRP tubes. The main objective is to measure the performance of the Vacusera PRP Tube and Vacusera PRP Tube with Gel in obtaining platelet-rich plasma. The study is entirely designed to analyze product performance, and no interventions will be performed.

Trial Locations (1)

35575

Medical Point Hastanesi Klinik Araştırmalar Merkezi, Izmir

All Listed Sponsors
lead

Disera Tıbbi Cihazlar Lojistik Sanayi ve Ticaret A.Ş

INDUSTRY